Loading...

GALT GALECTIN THERAPEUTICS INC Management Changes 8-K Filing

GLCT

GLT

GALECTIN THERAPEUTICS INC

(GALT)

2026 8-K

Financial Results

Board Appointment

Retention Bonuses Approved

Director Resignation

Credit Agreement Details

Annual Meeting Results

Annual Meeting Update

Financial Update

Trial Results Announcement

Corporate Update

Financial Update

Compensatory Arrangements o...

Financial Statements

Investor Meetings

Financial Results

Corporate Presentation

Press Release Issued

Annual Meeting Results

Stockholder Meeting

Corporate Presentation

Press Release Issued

Corporate Presentation

Financial Results

Corporate Presentation

Financial Results

Promotion of Dr. Khurram Jamil

Financial Results

Earnings Reports

Annual Meeting of Stockholders

Financial Results

Financial Results Announcement

Earnings Report

Financial Results

Financial Results Announcement

External Links:

On January 16, 2026, Galectin Therapeutics Inc. announced cash retention bonuses of $300,000 for Chief Medical Officer Dr. Khurram Jamil and $150,000 for Chief Financial Officer Jack Callicutt, payable in three installments throughout 2026, with conditions for repayment applicable.

AI Assistant

GALECTIN THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.